Clinical Trials in Arizona

Showing 8201-8220 of 16,770 trials

Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19

NCT04358549

To determine the effect of favipiravir + SOC v. SOC on COVID-19 viral clearance.

Fujifilm Pharmaceuticals U.S.A., Inc.50 participantsStarted Apr 2020

Scottsdale, Arizona, United States • Miami, Florida, United States • Boston, Massachusetts, United States +5 more locations

COMPLETEDPhase 333 miles

Evaluation of Dupilumab in Children With Uncontrolled Asthma

NCT02948959

Primary Objective: To evaluate the efficacy of dupilumab in children 6 to less than (\<) 12 years of age with uncontrolled persistent asthma. Secondary Objective: To evaluate in children 6 to \<12 years of age with uncontrolled persistent asthma: * The safety and tolerability of dupilumab. * The evaluate the effect of dupilumab in improving participant reported outcomes including health related quality of life. * The dupilumab systemic exposure and incidence of anti-drug antibodies. * The evaluate the association between dupilumab treatment and pediatric immune responses to vaccines: any vaccination for tetanus, diphtheria, pertussis and/or seasonal trivalent/quadrivalent influenza vaccine.

Asthma

Sanofi408 participantsStarted Apr 2017

Birmingham, Alabama, United States • Gilbert, Arizona, United States • Tucson, Arizona, United States +96 more locations

Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19

Evaluation of Dupilumab in Children With Uncontrolled Asthma

Find Trials by Condition in Arizona

Improving Pain Management and Decreasing LOS After Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA)

A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors

Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus

Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine

Post Market Study of the 3DKnee™ With E-plus Insert

Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status

NSABP Patient Registry and Biospecimen Profiling Repository

Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure

Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children

Combination Study for High Risk Multiple Myeloma Patients

The National Standard for Normal Fetal Growth

Repeat Antenatal Steroids Trial

Safety and Immunogenicity of Fluzone® Quadrivalent, Flublok® Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2018-2019 Formulations

PERL Continuous Glucose Monitoring (CGM) Study

CV-SQuISH-ED: Clinical Validation Study

Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)